Compounds > rilmenidine
Page last updated: 2024-08-25

rilmenidine and oxymetazoline

rilmenidine has been researched along with oxymetazoline in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agbaba, D; Filipic, S; Nikolic, K1
Hébert, CA; Kudo, LH; Rouch, AJ1
Bönisch, H; Brüss, M; Göthert, M; Likungu, J; Molderings, GJ1
Bonisch, H; Bruss, M; Gothert, M; Molderings, GJ1

Other Studies

4 other study(ies) available for rilmenidine and oxymetazoline

ArticleYear
QSAR study of imidazoline antihypertensive drugs.
    Bioorganic & medicinal chemistry, 2008, Aug-01, Volume: 16, Issue:15

    Topics: Antihypertensive Agents; Binding Sites; Imidazoline Receptors; Imidazolines; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship

2008
Inhibition of water permeability in the rat collecting duct: effect of imidazoline and alpha-2 compounds.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1999, Volume: 221, Issue:2

    Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Animals; Arginine Vasopressin; Clonidine; Cyclic AMP; Dose-Response Relationship, Drug; Imidazoles; Kidney Tubules, Collecting; Medetomidine; Oxazoles; Oxymetazoline; Permeability; Rats; Rats, Wistar; Rilmenidine; Water

1999
Species-specific pharmacological properties of human alpha(2A)-adrenoceptors.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 36, Issue:3

    Topics: Adrenergic alpha-Agonists; Adult; Aged; Amino Acid Sequence; Animals; Antihypertensive Agents; Female; Heart Atria; Humans; Imidazoles; Male; Middle Aged; Molecular Sequence Data; Norepinephrine; Oxazoles; Oxymetazoline; Pulmonary Artery; Rabbits; Receptors, Adrenergic, alpha-2; Rilmenidine; Species Specificity; Tritium

2000
Alpha(2A)-adrenergic versus imidazoline receptor controversy in rilmenidine's action: alpha(2A)-antagonism in humans versus alpha(2A)-agonism in rabbits.
    Annals of the New York Academy of Sciences, 2003, Volume: 1009

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Amino Acid Sequence; Animals; Antihypertensive Agents; Humans; Imidazoline Receptors; Molecular Sequence Data; Oxazoles; Oxymetazoline; Rabbits; Receptors, Adrenergic, alpha-2; Receptors, Drug; Rilmenidine; Sequence Alignment

2003